Key result
Prenatal diagnosis of congenital heart disease via echocardiography at 13 to 17 weeks improves fetal outcomes, while managing fetal arrhythmias requires careful consideration of treatment safety.
Prenatal diagnosis of congenital heart disease and appropriate management of fetal arrhythmias are important for improving fetal outcomes.
Answers are grounded in this paper and cite their sources.
Supports fetal cardiology integration; leaves open optimal echocardiography timing and arrhythmia therapy safety in prospective studies.
The prevalence of congenital heart disease increases with increasing NT, and many defects can be detected by echocardiography performed by a specialist at 13 to 17 weeks. There is increasing evidence that a prenatal diagnosis improves fetal outcome. Physiology and pathophysiology of the human fetal pulmonary circulation play an important role in the fetal circulation, and recent studies about the reactivity of these vessels in the third trimester have contributed to increase our understanding. The main issue in fetal arrhythmias (brady- and tachycardia) is the correct indication, efficacy, and safety of treatment.
No takes yet. Share an insight, caveat, or question.
Gerald Tulzer (2000) conducted a review in Congenital heart disease and fetal arrhythmias. Prenatal diagnosis of congenital heart disease via echocardiography at 13 to 17 weeks improves fetal outcomes, while managing fetal arrhythmias requires careful consideration of treatment safety.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: